An upregulation of CD8+CD25+Foxp3+ T cells with suppressive function through interleukin 2 pathway in pulmonary arterial hypertension-Reference-Cited by-全球学者库

An upregulation of CD8+CD25+Foxp3+ T cells with suppressive function through interleukin 2 pathway in pulmonary arterial hypertension

Published:2017-09 Issue:2 Volume:358 Page:182-187
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Zhu Rong,Chen Liang,Xiong Yaqiong,Wang Nana,Xie Xiaochen,Hong Yongqing,Meng Zili

Publisher

Elsevier BV

Subject

Cell Biology

Reference28 articles.

1. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension;Rabinovitch;Circ. Res.,2014

2. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial;Galiè;Lancet,2008

3. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus;Bonelli;J. Immunol.,2009

4. M.I. Covas, A. Esquerda, A. García-Rico, N. Mahy, Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease., J. Investig. Allergol. Clin. Immunol. 2 (n.d.) 131–135.

5. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension;Tamby;Eur. Respir. J.,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lasso algorithm and support vector machine strategy to screen pulmonary arterial hypertension gene diagnostic markers;Scottish Medical Journal;2022-10-17

2. Immune Cells in Pulmonary Arterial Hypertension;Heart, Lung and Circulation;2022-07

3. FOXP3, IL2R, CD8A and RORγ gene expression in peripheral blood leukocytes of healthy people and patients with arterial hypertension;Medical Immunology (Russia);2022-04-20

4. Role of the Immune System Elements in Pulmonary Arterial Hypertension;Journal of Clinical Medicine;2021-08-23

5. Biological drug and drug delivery-mediated immunotherapy;Acta Pharmaceutica Sinica B;2021-04